Search - tctmd.com

Displaying 661 - 680 of 4351

Sort: Relevancy | Date

Presentation TCT 2022

Get With the Program: Patient-Oriented Outcomes Are Key

Presenter: Davide Capodanno

September 17, 2022

Presentation TCT 2022

TCT 280: Combined Use of Hyperemic and Non-Hyperemic Pressure Ratios for Revascularization Decision-Making

Presenter: Coen Boerhout

September 17, 2022

Presentation TCT 2022

Revascularization in LV Systolic Dysfunction: Revived or Dead?

Presenter: Divaka Perera

September 17, 2022

Presentation TCT 2022

TCT 68: Complete Revascularisation in Patients Presenting with ST-Elevation MI, Cardiogenic Shock and Multi-vessel Disease is Associated With Higher Mortality at 30 Days, 1 Year and up to 30 Months Follow-up

Presenter: Alexander Tindale

September 17, 2022

Presentation TCT 2022

TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial

Presenter: Zardasht Oqab

September 17, 2022

Presentation TCT 2022

TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial

Presenter: Kevin Bainey

September 17, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Routine Functional Testing Unnecessary After Stenting: POST-PCI

Yael L. Maxwell

September 06, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

Presentation ESC 2022

Percutaneous Revascularisation for Ischaemic Left Ventricular Dysfunction

Presenter: Divaka Perera

August 27, 2022

Presentation ESC 2022

Percutaneous Revascularisation for Ischaemic Left Ventricular Dysfunction

Presenter: Divaka Perera

August 27, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Todd Neale

August 19, 2022

Advertisement

Get With the Program: Patient-Oriented Outcomes Are Key

TCT 280: Combined Use of Hyperemic and Non-Hyperemic Pressure Ratios for Revascularization Decision-Making

Revascularization in LV Systolic Dysfunction: Revived or Dead?

TCT 68: Complete Revascularisation in Patients Presenting with ST-Elevation MI, Cardiogenic Shock and Multi-vessel Disease is Associated With Higher Mortality at 30 Days, 1 Year and up to 30 Months Follow-up

TCT 36: Complete revascularization versus culprit lesion only PCI in patients with diabetes mellitus and multivessel coronary artery disease: A subgroup analysis of the COMPLETE trial

TCT 35: Effects of Complete Revascularization According to Age in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel: Insights from the COMPLETE Trial

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

CV Care Around Noncardiac Surgery: New ESC Guidelines

Routine Functional Testing Unnecessary After Stenting: POST-PCI

September 2022 News Roundup

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Percutaneous Revascularisation for Ischaemic Left Ventricular Dysfunction

Percutaneous Revascularisation for Ischaemic Left Ventricular Dysfunction

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Polypill Bests Usual Care in Patients With Recent MI: SECURE

What’s Going to Be Hot at ESC 2022?

Even With Revascularization in ISCHEMIA, Skipping Meds Hurt Health Status

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content